Search Results for: simon harris

Ultrasound is generally perceived as an essential diagnostic tool, and it is widely used in many clinical applications. With the use of ultrasound spreading quickly to point-of-care applications, such as emergency medicine, intensive care, anaesthesia, and more, it is becoming ubiquitous throughout healthcare systems.

Due to COVID-19, ECR 2020 was an online only congress and was streamed live between July 15-19, 2020. Signify Research analysts provided insights for the ECR today Daily Congress News.

After a record year in 2018, the current world trade slowdown is taking its toll on the ultrasound market and the outlook for 2019 is for slower growth.

At ECR this year, there were over 25 independent software vendors (ISVs), many of them start-ups, showcasing artificial intelligence (AI) solutions for medical imaging within a dedicated space.

Capital investment in companies who are developing machine learning solutions for medical image analysis reached $522 million by the end of the first half of 2018. There was a surge of investment towards the end of 2017, with nine deals completed in Q4 2017 worth a combined $141 million. This has continued into 2018, with deal value reaching $143 million across nine deals in the year-to-date.

For the first time at ECR there was a dedicated section of the Expo for AI, the Artificial Intelligence Future Lab, with seven exhibitors and a mini-theatre for presentations. There were also a handful of medical imaging AI companies dotted around the main exhibition halls and most of the major vendors found an angle to add AI to their booths.

There were several ultrasound product launches from the major vendors at ECR 2018, with most prioritising workflow efficiency and image quality over advanced clinical features. Large displays, faster boot times, manoeverability and improved ergonomics were common across the product launches, with vendors striving to make ultrasound faster, more precise and more affordable. This insight summarises the products announced alongside our views on their likely impact on the market.